UBS Group »

Purple Biotech shares owned by UBS Group

Quarter-by-quarter ownership of Purple Biotech (PPBT) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Purple Biotech

Tip: Access up to 7 years of quarterly data

All positions including Purple Biotech held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Purple Biotech by UBS Group

Quarter filed Position value Share count Share price at filing
2026-03-31 $399 99 4.04

More positions owned by UBS Group

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Amazon (AMZN)
Meta Platforms Cl A (META)
Spdr Gold Tr Gold Shs (GLD)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core Msci Eafe (IEFA)
Alphabet Cap Stk Cl C (GOOG)
Taiwan Semiconductor Manufac Sponsored Ads (TSM)
Ubs Group SHS (UBS)

View all positions for UBS Group

Top funds holding Purple Biotech

SmartHarvest Portfolios
Bnp Paribas Arbitrage, Snc
Rhumbline Advisers
Morgan Stanley
GAMMA Investing
UBS Group
SBI Securities
Group One Trading
Royal Bank of Canada
Northwestern Mutual Wealth Management Company
Danske Bank A/s

View all funds holding Purple Biotech